(Q42440485)

31 October 2017

NOX1 abet mesangial fibrogenesis via iNOS induction in diabetes (English)

1 reference

31 October 2017

Ling Gao

1

1 reference

PubMed ID

23801050

31 October 2017

Weilu Huang

series ordinal

2

1 reference

PubMed ID

23801050

31 October 2017

Jing Li

series ordinal

3

1 reference

31 October 2017

26 June 2013

1 reference

Molecular and Cellular Biochemistry

31 October 2017

1 reference

31 October 2017

382

1 reference

31 October 2017

1-2

1 reference

31 October 2017

185-191

1 reference

https://scigraph.springernature.com/pub.10.1007/s11010-013-1733-4

31 October 2017

0 references

cites work

Chronic diabetic nephropathy: role of inducible nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1733-4

Nox 2 stimulates muscle differentiation via NF-kappaB/iNOS pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1733-4

Introduction to serial reviews: physiological relevance of antioxid/redox genes; learning from genetically modified animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1733-4

Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1733-4

Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1733-4

Curcumin ameliorates diabetic nephropathy by inhibiting the activation of the SphK1-S1P signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1733-4

Activation of RhoA/ROCK regulates NF-κB signaling pathway in experimental diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1733-4

Potential role for Nrf2 activation in the therapeutic effect of MG132 on diabetic nephropathy in OVE26 diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1733-4

Intrarenal localization of nitric oxide synthase isoforms and soluble guanylyl cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1733-4

Effect of angiotensin type 2 receptor over-expression on the rat mesangial cell fibrotic phenotype: effect of gender

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1733-4

Advanced glycosylation end products induce inducible nitric oxide synthase (iNOS) expression via a p38 MAPK-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1733-4

Protein glycation: a firm link to endothelial cell dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1733-4

A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1733-4

Reactive oxygen species-regulated signaling pathways in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1733-4

iNOS expression requires NADPH oxidase-dependent redox signaling in microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1733-4

Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1733-4

The p47phox- and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1) mediates endothelial nitric oxide synthase (eNOS) uncoupling and endothelial dysfunction in a streptozotocin-induced murine model of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1733-4

Peroxynitrite plays a key role in glomerular lesions in diabetic rats

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23801050

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

End-stage renal disease due to diabetes in racial/ethnic minorities and disadvantaged populations

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23801050

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glom

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23801050

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11010-013-1733-4

1 reference

31 October 2017

1 reference

PubMed ID

23801050